{"id":"https://openalex.org/W2097828587","doi":"https://doi.org/10.1164/ajrccm.156.6.9611100","title":"Effects of Inter- \u03b1 -inhibitor in Experimental Endotoxic Shock and Disseminated Intravascular Coagulation","display_name":"Effects of Inter- \u03b1 -inhibitor in Experimental Endotoxic Shock and Disseminated Intravascular Coagulation","publication_year":1997,"publication_date":"1997-12-01","ids":{"openalex":"https://openalex.org/W2097828587","doi":"https://doi.org/10.1164/ajrccm.156.6.9611100","mag":"2097828587","pmid":"https://pubmed.ncbi.nlm.nih.gov/9412562"},"language":"en","primary_location":{"id":"doi:10.1164/ajrccm.156.6.9611100","doi":"https://doi.org/10.1164/ajrccm.156.6.9611100","is_oa":false,"landing_page_url":"https://doi.org/10.1164/ajrccm.156.6.9611100","pdf_url":null,"source":{"id":"https://openalex.org/S93356601","display_name":"American Journal of Respiratory and Critical Care Medicine","issn_l":"1073-449X","issn":["1073-449X","1535-4970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Respiratory and Critical Care Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057395882","display_name":"Merc\u00e9 Jourdain","orcid":"https://orcid.org/0000-0001-9450-192X","observed_orcids":["https://orcid.org/0000-0001-9450-192X"]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210101212","display_name":"H\u00f4pital Roger Salengro","ror":"https://ror.org/0165ax130","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"MERC\u00c9 JOURDAIN","raw_affiliation_strings":["Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I4210101212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111637585","display_name":"Odile Carrette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210101212","display_name":"H\u00f4pital Roger Salengro","ror":"https://ror.org/0165ax130","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"ODILE CARRETTE","raw_affiliation_strings":["Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I4210101212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064940562","display_name":"Antoine Tournoys","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210101212","display_name":"H\u00f4pital Roger Salengro","ror":"https://ror.org/0165ax130","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"ANTOINE TOURNOYS","raw_affiliation_strings":["Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I4210101212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111776364","display_name":"Fran\u00e7ois Fourrier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210101212","display_name":"H\u00f4pital Roger Salengro","ror":"https://ror.org/0165ax130","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"FRAN\u00c7OIS FOURRIER","raw_affiliation_strings":["Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I4210101212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037932970","display_name":"C Mizon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210101212","display_name":"H\u00f4pital Roger Salengro","ror":"https://ror.org/0165ax130","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"CHARLOTTE MIZON","raw_affiliation_strings":["Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I4210101212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058766371","display_name":"Jacques Mangalaboyi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210101212","display_name":"H\u00f4pital Roger Salengro","ror":"https://ror.org/0165ax130","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"JACQUES MANGALABOYI","raw_affiliation_strings":["Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I4210101212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082784881","display_name":"Jenny Goudemand","orcid":"https://orcid.org/0000-0003-3019-3299","observed_orcids":["https://orcid.org/0000-0003-3019-3299"]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210101212","display_name":"H\u00f4pital Roger Salengro","ror":"https://ror.org/0165ax130","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"JENNY GOUDEMAND","raw_affiliation_strings":["Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I4210101212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008247564","display_name":"Jacques Mizon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210101212","display_name":"H\u00f4pital Roger Salengro","ror":"https://ror.org/0165ax130","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"JACQUES MIZON","raw_affiliation_strings":["Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I4210101212"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022202148","display_name":"Claude Chopin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210101212","display_name":"H\u00f4pital Roger Salengro","ror":"https://ror.org/0165ax130","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"CLAUDE CHOPIN","raw_affiliation_strings":["Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Equipe recommand\u00e9e 150. DRED, Equipe associ\u00e9e 1052, DRED, Equipe d'accueil 1044. DRED, Universit\u00e9 de Lille II, and Service de R\u00e9animation Polyvalente, H\u00f4pital Roger Salengro, Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I4210101212"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6245,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.71467059,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"156","issue":"6","first_page":"1825","last_page":"1833"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.5156000256538391,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.5156000256538391,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11116","display_name":"Trauma, Hemostasis, Coagulopathy, Resuscitation","score":0.3953000009059906,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.06369999796152115,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inter-alpha-inhibitor","display_name":"inter-alpha-inhibitor","score":0.9620000123977661},{"id":"https://openalex.org/keywords/endotoxic-shock","display_name":"endotoxic shock","score":0.8880000114440918},{"id":"https://openalex.org/keywords/disseminated-intravascular-coagulation","display_name":"disseminated intravascular coagulation","score":0.972000002861023},{"id":"https://openalex.org/keywords/endotoxin","display_name":"endotoxin","score":0.7360000014305115},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9089999794960022},{"id":"https://openalex.org/keywords/hemodynamics","display_name":"hemodynamics","score":0.6370000243186951},{"id":"https://openalex.org/keywords/oxygenation","display_name":"oxygenation","score":0.8799999952316284},{"id":"https://openalex.org/keywords/pulmonary-hypertension","display_name":"pulmonary hypertension","score":0.8410000205039978},{"id":"https://openalex.org/keywords/thrombin-antithrombin-complex","display_name":"thrombin-antithrombin complex","score":0.9049999713897705},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor-1","display_name":"plasminogen activator inhibitor-1","score":0.9879999756813049},{"id":"https://openalex.org/keywords/antithrombin-iii","display_name":"antithrombin III","score":0.8840000033378601},{"id":"https://openalex.org/keywords/von-willebrand-factor","display_name":"von Willebrand factor","score":0.8930000066757202},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.972000002861023},{"id":"https://openalex.org/keywords/pig-model","display_name":"porcine model","score":0.7319999933242798}],"concepts":[{"id":"https://openalex.org/C2779679481","wikidata":"https://www.wikidata.org/wiki/Q13581432","display_name":"Plasminogen activator","level":2,"score":0.7374714016914368},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6750091910362244},{"id":"https://openalex.org/C2779026020","wikidata":"https://www.wikidata.org/wiki/Q416336","display_name":"Antithrombin","level":3,"score":0.633798360824585},{"id":"https://openalex.org/C178853913","wikidata":"https://www.wikidata.org/wiki/Q1642137","display_name":"Hemodynamics","level":2,"score":0.48443320393562317},{"id":"https://openalex.org/C2776452961","wikidata":"https://www.wikidata.org/wiki/Q1940733","display_name":"Mean arterial pressure","level":4,"score":0.4733167886734009},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4696340560913086},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4618048071861267},{"id":"https://openalex.org/C2780675426","wikidata":"https://www.wikidata.org/wiki/Q410485","display_name":"Plasminogen activator inhibitor-1","level":3,"score":0.4531441628932953},{"id":"https://openalex.org/C2781300812","wikidata":"https://www.wikidata.org/wiki/Q178061","display_name":"Shock (circulatory)","level":2,"score":0.44999822974205017},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.44913920760154724},{"id":"https://openalex.org/C2779394231","wikidata":"https://www.wikidata.org/wiki/Q412310","display_name":"Von Willebrand factor","level":3,"score":0.41350260376930237},{"id":"https://openalex.org/C2776825266","wikidata":"https://www.wikidata.org/wiki/Q1410794","display_name":"Fibrinolysis","level":2,"score":0.4125558137893677},{"id":"https://openalex.org/C2777628635","wikidata":"https://www.wikidata.org/wiki/Q1765564","display_name":"Septic shock","level":3,"score":0.4106071889400482},{"id":"https://openalex.org/C2778384902","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Sepsis","level":2,"score":0.35561907291412354},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.2852690815925598},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.15032458305358887},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.10523432493209839},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.08623698353767395}],"mesh":[{"descriptor_ui":"D000510","descriptor_name":"Alpha-Globulins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000990","descriptor_name":"Antithrombin III","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D001772","descriptor_name":"Blood Cell Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004211","descriptor_name":"Disseminated Intravascular Coagulation","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004211","descriptor_name":"Disseminated Intravascular Coagulation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D004211","descriptor_name":"Disseminated Intravascular Coagulation","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004211","descriptor_name":"Disseminated Intravascular Coagulation","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005340","descriptor_name":"Fibrinogen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008070","descriptor_name":"Lipopolysaccharides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010100","descriptor_name":"Oxygen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010447","descriptor_name":"Peptide Hydrolases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D010959","descriptor_name":"Tissue Plasminogen Activator","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D011517","descriptor_name":"Prothrombin Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D013552","descriptor_name":"Swine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D014841","descriptor_name":"von Willebrand Factor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017395","descriptor_name":"Plasminogen Activator Inhibitor 1","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D019344","descriptor_name":"Lactic Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1164/ajrccm.156.6.9611100","doi":"https://doi.org/10.1164/ajrccm.156.6.9611100","is_oa":false,"landing_page_url":"https://doi.org/10.1164/ajrccm.156.6.9611100","pdf_url":null,"source":{"id":"https://openalex.org/S93356601","display_name":"American Journal of Respiratory and Critical Care Medicine","issn_l":"1073-449X","issn":["1073-449X","1535-4970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Respiratory and Critical Care Medicine","raw_type":"journal-article"},{"id":"pmid:9412562","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9412562","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of respiratory and critical care medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.6899999976158142,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1525704090","https://openalex.org/W1593285591","https://openalex.org/W1652278102","https://openalex.org/W1772585163","https://openalex.org/W1790654406","https://openalex.org/W1820585906","https://openalex.org/W1949759626","https://openalex.org/W1970580268","https://openalex.org/W1976227558","https://openalex.org/W1992644897","https://openalex.org/W2002784206","https://openalex.org/W2011167229","https://openalex.org/W2012587507","https://openalex.org/W2017891133","https://openalex.org/W2018745526","https://openalex.org/W2019035349","https://openalex.org/W2043327576","https://openalex.org/W2058486347","https://openalex.org/W2064483550","https://openalex.org/W2079403357","https://openalex.org/W2081429676","https://openalex.org/W2092800556","https://openalex.org/W2093504766","https://openalex.org/W2102317371","https://openalex.org/W2111685551","https://openalex.org/W2140439211","https://openalex.org/W2153245357","https://openalex.org/W2164729929","https://openalex.org/W2306341119","https://openalex.org/W2409172422","https://openalex.org/W2412198256","https://openalex.org/W2461821928"],"related_works":["https://openalex.org/W2083659341","https://openalex.org/W2050276942","https://openalex.org/W4399433043","https://openalex.org/W2035502900","https://openalex.org/W2040930510","https://openalex.org/W2553286504","https://openalex.org/W2088123918","https://openalex.org/W2409043137","https://openalex.org/W2053515242","https://openalex.org/W2395397316"],"abstract_inverted_index":{"We":[0,77,247],"investigated":[1],"the":[2,128,164,187,196,204,211,267],"effects":[3],"of":[4,20,25,89,191,254],"human":[5],"inter-alpha-inhibitor":[6],"(I":[7],"alpha":[8,34,41,63,75,112,130,135,155,168,172,193,258],"I)":[9],"on":[10],"hemodynamics,":[11],"oxygenation,":[12,269],"and":[13,58,80,86,110,116,124,146,200,208,217,227,270],"coagulation":[14,84,271],"parameters":[15],"in":[16,210,214,224,241,250,262,266],"a":[17,263],"porcine":[18],"model":[19,253],"endotoxic":[21],"shock.":[22],"Four":[23],"groups":[24],"six":[26],"animals":[27],"were":[28,234],"studied:":[29],"(1)":[30],"control,":[31],"(2)":[32],"I":[33,35,40,42,62,64,74,111,113,129,131,134,136,154,156,167,169,171,173,192,194,257,259],"group":[36,48,65],"receiving":[37,49,66],"30":[38,44,56,67,71],"mg/kg":[39],"over":[43,55],"min,":[45,57],"(3)":[46],"LPS":[47,60,188],"5":[50],"micrograms.kg/min":[51],"Escherichia":[52],"coli":[53],"endotoxin":[54,70,255],"(4)":[59],"+":[61,166],"min":[68,73],"after":[69,144],"mg/kg/30":[72],"I.":[76],"measured":[78],"hemodynamic":[79],"oxygenation":[81],"parameters,":[82],"usual":[83],"markers":[85],"plasma":[87,133,174,242],"levels":[88,137,175,233],"thrombin-antithrombin":[90,225],"complexes,":[91],"antithrombin":[92],"III":[93],"activity,":[94],"plasminogen":[95,99,228],"activator":[96,100,229],"tissue":[97],"type,":[98],"inhibitor":[101,230],"type":[102,231],"1,":[103],"von":[104],"Willebrand":[105],"factor,":[106],"tumor":[107,243],"necrosis":[108,244],"factor-alpha,":[109],"at":[114,117,151,182],"baseline":[115],"30,":[118],"60,":[119],"90,":[120],"120,":[121],"180,":[122],"240,":[123],"300":[125,152,183],"min.":[126,153,184],"In":[127,163],"group,":[132,170,189],"reached":[138],"447":[139],"+/-":[140,148,160],"23":[141],"mg/L":[142,150,181],"just":[143],"injection":[145],"287":[147],"39":[149],"half-life":[157],"was":[158,237],"7.3":[159],"1.9":[161],"h.":[162],"IPS":[165],"decreased":[176],"more":[177],"rapidly,":[178],"reaching":[179],"260":[180],"Compared":[185],"with":[186],"administration":[190,260],"normalized":[195],"mean":[197],"arterial":[198],"pressure":[199],"cardiac":[201],"index,":[202],"improved":[203],"LPS-induced":[205],"pulmonary":[206],"hypertension,":[207],"resulted":[209,261],"blunted":[212],"increase":[213],"blood":[215],"lactate":[216],"oxygen":[218],"extraction":[219],"ratio.":[220],"A":[221],"significant":[222,239],"decrease":[223],"complexes":[226],"1":[232],"observed.":[235],"There":[236],"no":[238],"difference":[240],"factor-alpha":[245],"levels.":[246],"concluded":[248],"that":[249],"this":[251],"hypodynamic":[252],"shock,":[256],"marked":[264],"improvement":[265],"hemodynamic,":[268],"parameters.":[272]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}